Brief: Panacea Biotec To Make Up To 25 Mln Doses Of Sputnik V Vaccine
Aug 5 (Reuters) - Panacea Biotec Ltd PNCA.NS :
* ENTERED LICENSING AND MANUFACTURING AGREEMENT WITH HUMAN
VACCINE
LIMITED LIABILITY CO ON AUG 3
* AGREEMENT IS FOR MANUFACTURE OF UPTO 25 MILLION DOSES OF
SPUTNIK
V VACCINE
* AGREEMENT WITH A UNIT OF RUSSIAN DIRECT INVESTMENT FUND
AND DR.
REDDY'S JV
Source text for Eikon: ID:nBSE9QTHMV
Further company coverage: PNCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panacea Biotec
See all newsBrief: Panacea Biotec Receives Letter Of Award For BOPV Supply Worth $8.205 Million
Brief: Panacea Biotec Unit Gets Show Cause Notice Alleging Total Tax Liability Of 40.6 Million Rupees
Brief: Panacea Biotec Files Appeal Against Fourth Industrial Tribunal (Mohali) Award
India's Panacea Biotec rises to record high on EU-backed dengue vaccine project
India Stocks: Indian shares rise as banks gain on RBI forex swap facility